3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Pregnancy -

Better drugs needed for pregnant women in tropics

PregnancyJun 18, 08

More studies are urgently needed to find new and improved drugs to treat tropical diseases in pregnant women, scientists in Thailand said.

In an article published in PLoS Medicine, they said that while governments in developed countries had begun encouraging pharmaceutical companies to find new drugs for pregnant women, this was visibly absent in the tropics.

“There are few or no studies in pregnancy on most drugs used for the treatment of tropical infections, and so, few or no evidence-based recommendations,” Nicholas White and his colleagues at Mahidol University’s Mahidol-Oxford Tropical Medicine Research Unit wrote.

As such, pregnant women in these regions who are infected with potentially fatal illnesses may be treated with inferior drugs to avoid a hypothetical risk to the unborn child.

Out of an estimated 536,000 maternal deaths in the world in 2005, 533,000 or 99 percent occurred in developing countries in the tropics, they added.

The scientists, who are all malaria experts, said better drugs were needed in particular to treat malaria in pregnancy, which threatens the life of both mother and child.

Malaria in pregnancy reduces birth weight, and thereby, infant survival. Even when the mother is asymptomatic, the presence of malaria parasites in the blood is always harmful to the fetus and must be treated promptly and effectively, they said.

The scientists used the example of artesunate, a compound extracted from the Sweet Wormwood shrub and which is regarded by medical experts as the best treatment for malaria.

Although it has been shown to reduce the death rate of severe malaria by 35 percent compared with quinine, the latter is still the most widely used treatment for severe malaria in pregnancy.

“Somehow, the unknown, but certainly very small, risk to the fetus posed by artesunate is considered to exceed the 35 percent increased risk of both mother and baby dying from malaria,” they wrote.

They called on international agencies and investors to support studies to find treatment for tropical diseases in pregnancy.

“We do not know how best to treat most tropical infectious diseases in pregnancy. It is a difficult problem, but one that should no longer be ignored,” they wrote.

HONG KONG (Reuters)



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Drug prevents passage of HBV during pregnancy
  BGI study confirms accuracy of its NIFTY in nearly 147,000 pregnancies
  Arkansas to appeal ruling on abortion restriction law
  Immune system ‘overdrive’ in pregnant women puts male child at risk for brain disorders
  Is it safe for pregnant women to eat peanuts?
  Preterm birth of mother increases risk of pregnancy complications
  U.S. teen birth rate lowest since 1946
  Vitamin D supplements found to be safe for healthy pregnant women
  Study finds that folate does not offer protection against preterm delivery
  New tests and interventions may help prevent future health problems
  UNC Miscarriage Expert Available to Comment on Bush’s Miscarriage Disclosure
  Pregnancy outcome affected by immune system genes

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site